Community/Retail

Tofacitinib is the first and only Janus kinase inhibitor approved by the FDA for this patient population.

Screening for colorectal cancer (CRC) should begin at age 45 for people of average risk, according to newly updated American Cancer Society guidelines.

Shingrix (Recombinant zoster vaccine) has been associated with vaccine administration errors since it hit the market, according to a new CDC report.

One lot of TAYTULLA Softgel capsules sample packs (1 mg/20mcg, 6x28 size) has been voluntarily recalled by Allergan.

A study compares changes in medication regimen complexity in patients with uncontrolled T2D who were referred to a collaborative pharmacist-endocrinologist.

An Interview with Dr. Hien Nguygen, a PGY-1 Resident at Penn Medicine Lancaster General Health who has a love for geriatric pharmacy

LifePlus has announced their product Lifeleaf, which is an noninvasive monitor for glucose, blood pressure, heart rate, respiration rate, and oxygen saturation. How can change the field of wearables?

The hepatitis C virus (HCV) guidelines for unique populations have recently been updated.

Allergic reaction points up weak science behind some companies that offer dermatological solutions.

In this clip, Nimit Jindal, a PharmD candidate at the Rutgers University Ernest Mario School of Pharmacy, shares his thoughts on Provider Status and how student pharmacists can advocate for it.

We talk to 5 more pharmacists with exciting side hustles

Interview well, get an offer, and end the employment intermission.

How can you engage patients to adapt healthy behaviors and be adherent? Motivational Interviewing may be the missing piece.

Learn why pharmacists are in a great position to join the fastest-growing area in health care: technology

Looking to differentiate your pharmacy? These easy strategies can help your patients and increase rapport and retention.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

Novel enzyme therapy for adults with PKU, a rare genetic disease, has won approval from the agency.

We spend much of our time talking about work-life balance, and chasing after it, but such a balance is not possible.

On May 28, Walgreens is offering a Memorial Day 20% discount to all veterans, active duty military personnel and their immediate family members, including the families of those who lost their lives in service to our country.

The FDA has approved an updated label for Eli Lilly’s ixekizumab (Taltz) injection 80 mg/mL to include data in psoriasis involving the genital area.

The FDA is taking new steps to ensure products being marketed to protect consumers from the sun’s harmful effects deliver on their promises, as it recognizes No Fry Day.

In this clip, Ben Urick, PharmD, PhD, a research assistant professor at the University of North Carolina Eshelman School of Pharmacy, discusses his research on quality measures.

The FDA has issued a warning to patients to avoid using OTC benzocaine teething products due to the risk of a dangerous condition, methemoglobinemia.

In this clip, Ben Urick, PharmD, PhD, a research assistant professor at the University of North Carolina Eshelman School of Pharmacy, discusses the value that the Pharmacy Quality Alliance (PQA) brings to the health care system.

In this clip, Ben Urick, PharmD, PhD, a research assistant professor at the University of North Carolina Eshelman School of Pharmacy, shared his advice for student pharmacists.

Critical care pharmacists ensure optimal pharmaceutical care in critically ill patients.

Health care professionals and consumers are encouraged to report any adverse events related to these products to the FDA’s MedWatch Adverse Event Reporting program.

In this clip, Jim Flood, the chair of Crowell & Moring's Government Affairs Group, discusses why it's important for pharmacists to speak to political candidates.

In this clip, Jim Flood, the chair of Crowell & Moring's Government Affairs Group, discusses several public policy issues that pharmacists should follow.